Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models
双重 FAK/IGF-1R 激酶抑制剂 TAE226 在细胞和体内肿瘤模型中的药理学分析
期刊:BMC Research Notes
影响因子:1.6
doi:10.1186/s13104-019-4389-7
Shigemi Fukami, Daisaku Tomioka, Yutaka Murakami, Toshiyuki Honda, Shinji Hatakeyama
